Vesicular neurotransmitter transport and the presynaptic regulation of quantal size

Current Opinion in Neurobiology

Volumn 8, Issue 3, 1998, Pages 405-412

  Reimer, Richard J ^a   Fon, Edward A ^a   Edwards, Robert H ^a  

^a Depts of Neurology and Neurosurgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; MONOAMINE; NEUROTRANSMITTER; PROTEIN;

CELL TRANSPORT; EXOCYTOSIS; GENETIC MANIPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION;

EID: 0032104055     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(98)80068-8     Document Type: Article

References (44)

1. Schuldiner S, Shirvan A, Linial M. Vesicular neurotransmitter transporters: from bacteria to humans. Physiol Rev. 75:1995;369-392.
2. Liu Y, Edwards RH. The role of vesicular transport proteins in synaptic transmission and neural degeneration. Annu Rev Neurosci. 20:1997;125-156.
3. +-linked dopamine transport in chromaffin granule ghosts. Biochemistry. 20:1981;6625-6629.
4. Maycox PR, Deckwerth T, Hell JW, Jahn R. Glutamate uptake by brain synaptic vesicles. Energy dependence of transport and functional reconstitution in proteoliposomes. J Biol Chem. 263:1988;15423-15428.
5. Carlson MD, Kish PE, Ueda T. Characterization of the solubilized and reconstituted ATP-dependent vesicular glutamate uptake system. J Biol Chem. 264:1989;7369-7376.
6. Hell JW, Maycox PR, Jahn R. Energy dependence and functional reconstitution of the gamma-aminobutyric acid carrier from synaptic vesicles. J Biol Chem. 265:1990;2111-2117.
7. Sulzer D, Rayport S. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron. 5:1990;797-808.
8. Liu Y, Roghani A, Edwards RH. Gene transfer of a reserpine-sensitive mechanism of resistance to MPP+. Proc Natl Acad Sci USA. 89:1992;9074-9078.
9. Liu Y, Peter D, Roghani A, Schuldiner S, Prive G, Elsenberg D, Brecha N, Edwards RH. A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell. 70:1992;539-551.
10. Erickson JD, Eiden LE, Hoffman BJ. Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc Natl Acad Sci USA. 89:1992;10993-10997.
11. Alfonso A, Grundahl K, Duerr JS, Han H-P, Rand JB. The Caenorhabditis elegans unc-17 gene: a putative vesicular acetylcholine transporter. Science. 261:1993;617-619.
12. Roghani A, Feldman J, Kohan SA, Shirzadi A, Gundersen CB, Brecha N, Edwards RH. Molecular cloning of a putative vesicular transporter for acetylcholine. Proc Natl Acad Sci USA. 91:1994;10620-10624.
13. Erickson JD, Varoqui H, Schafer MD, Modi W, Diebler MF, Weihe E, Rand J, Eiden LE, Bonner TI, Usdin TB. Functional identification of a vesicular acetylcholine transporter and its expression from a 'cholinergic' gene locus. J Biol Chem. 269:1994;21929-21932.
14. Liu Y, Edwards RH. Differential localization of vesicular acetylcholine and monoamine transporters in PC12 cells but not CHO cells. of special interest J Cell Biol. 139:1997;907-916 This report documents the differential localization of VMATs and VAChT in PC12 cells that was suggested by Bauerfeind et al. 1993 [33]. VMATs localize preferentially to LDCVs whereas VAChT localizes preferentially to light vesicles, including SLMVs, in PC12 cells.
15. Varoqui H, Erickson JD. Active transport of acetylcholine by the human vesicular acetylcholine transporter. J Biol Chem. 271:1996;27229-27232.
16. Song H-j, Ming G-I, Fon E, Bellocchio E, Edwards RH, Poo M-m. Expression of putative vesicular acetylcholine transporter facilitates quantal transmitter packaging. of outstanding interest Neuron. 18:1997;815-826 Using a Xenopus culture system in which motor neurons form synapses with muscle cells, expression of VAChT in the motor neurons but not the muscle cells increases quantal size, indicating that the transporter can limit the rate of SV filling. VAChT expression also increases the frequency of release, presumably by increasing the detection of events, but increased VAChT expression may also increase the number of SVs capable of transmitter release. Neutralization of an aspartate in TMD10 of VAChT reduces the amount of transmitter packaged by the endogeneous wild-type transporter, possibly by promoting efflux.
17. Peter D, Jimenez J, Liu Y, Kim J, Edwards RH. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J Biol Chem. 269:1994;7231-7237.
18. Gracz LM, Wang W-C, Parsons SM. Cholinergic synaptic vesicle heterogeneity: evidence for regulation of acetylcholine transport. Biochemistry. 27:1988;5268-5274.
19. +/- mice show slightly increased sensitivity to the neurotoxin MPTP, consistent with a role for VMAT2 in protection against this form of toxicity (see Liu et al., 1992 [8]).
20. -/- animals and permits survival to several weeks. Heterozygotes show substantially reduced brain monoamine levels, presumably accounting for the behavioral defects observed in Takahashi et al., 1997 [19] and Wang et al., 1997 [21] and supporting a role for the vesicular transporters in regulating transmitter release.
21. +/- animals show dramatically increased sensitivity to apomorphine, cocaine, amphetamine and ethanol.
22. Desnos C, Raynaud B, Vidal S, Weber MJ, Scherman D. Induction of the vesicular monoamine transporter by elevated potassium concentration in culture of rat sympathetic neurons. Dev Brain Res. 52:1990;161-166.
23. Desnos C, Laran M, Scherman D. Regulation of the chromaffin granule catecholamine transporter in cultured bovine adrenal medullary cell-stimulus biosynthesis coupling. J Neurochem. 59:1992;2105-2112.
24. Krejci E, Gasnier B, Botton D, Isambert MF, Sagne C, Gagnon J, Massoulie J, Henry JP. Expression and regulation of the bovine vesicular monoamine transporter gene. FEBS Lett. 335:1993;27-32.
25. Cidon S, Tamir H, Nunez EA, Gershon MD. ATP-dependent uptake of 5-hydroxytryptamine by secretory granules isolated from thyroid parafollicular cells. J Biol Chem. 266:1991;4392-4400.
26. Tamir H, Piscopo I, Liu KP, Hsiung SC, Adlersberg M, Nicolaides M, al-Awqati Q, Nunez EA, Gershon MD. Secretagogue-induced gating of chloride channels in the secretory vesicles of parafollicular cells. Endocrinology. 135:1994;2045-2057.
27. Nakanishi N, Onozawa S, Matsumoto R, Hasegawa H, Yamada S. Effects of protein kinase inhibitors and protein phosphatase inhibitors on cyclic AMP-dependent down-regulation of vesicular monoamine transport in pheochromocytoma PC12 cells. FEBS Lett. 368:1995;411-414.
28. Krantz DE, Peter D, Liu Y, Edwards RH. Phosphorylation of a vesicular monoamine transporter by casein kinase II. J Biol Chem. 272:1997;6752-6759.
29. Kalivas PW, Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya. J Neurosci. 13:1993;276-284.
30. Nirenberg MJ, Liu Y, Peter D, Edwards RH, Pickel VM. The vesicular monoamine transporter-2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei. Proc Natl Acad Sci USA. 92:1995;8773-8777.
31. Nirenberg MJ, Chan J, Liu Y, Edwards RH, Pickel VM. Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine. of special interest J Neurosci. 16:1996;4135-4145 VMAT2 occurs in tubulovesicular structures of midbrain dopamine cell bodies and dendrites as well as in SVs and LDCVs in striatal terminals. Although these structures may simply represent an intermediate in transit from one compartment to another, these vesicles may also mediate the release of dopamine from midbrain cell bodies and dendrites described in Kalivas and Duffy, 1993 [29].
32. Liu Y, Schweitzer ES, Nirenberg MJ, Pickel VM, Evans CJ, Edwards RH. Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells. J Cell Biol. 127:1994;1419-1433.
33. Bauerfeind R, Regnier-Vigouroux A, Flatmark T, Huttner WB. Selective storge of acetylcholine, but not catecholamines, in neuroendocrine synaptic-like microvesicles of early endosomal origin. Neuron. 11:1993;105-121.
34. Weihe E, Tao-Cheng J-H, Schafer MK-H, Erickson JD, Eiden LE. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles. of special interest Proc Natl Acad Sci USA. 93:1996;3547-3552 Immuno-electron microscopy demonstrates VAChT in SVs of rat brain and in SLMVs of PC12 cells, supporting the difference in localization from that of the VMATs.
35. Merickel A, Rosandich P, Peter D, Edwards RH. Identification of residues involved in substrate recognition by a vesicular monoamine transporter. J Biol Chem. 270:1995;25798-25804.
36. of special interest Merickel A, Kaback HR, Edwards RH. Charged residues in transmembrane domains II and XI of a vesicular monoamine transporter form a charge pair that promotes high affinity substrates recognition. of special interest J Biol Chem. 272:1997;5403-5408 A highly conserved lysine in TMD2 of VMAT2 forms a charge pair with a highly conserved aspartate in TMD11. Neutralization of each residues alone eliminates transport activity but neutralization of both restores function, providing some of the first information about the packing of helices in these proteins.
37. + as measured by reserpine binding. Supporting a role for this residue in proton translocation, replacement of the aspartate with glutamate alters the pH profile for transport.
38. McIntire S, Jorgensen E, Horvitz HR. Genes required for GABA function in Caenorhabditis elegans. Nature. 364:1993;337-341.
39. McIntire SL, Reimer RJ, Schuske K, Edwards RH, Jorgensen EM. Identification and characterization of the vesicular GABA transporter. of special interest Nature. 389:1997;870-876 This report describes the identification of a genomic fragment from C. elegans that complements the defect in unc-47, a mutant with a presynaptic defect in GABAergic transmission. A vertebrate homolog has a pattern of expression restricted to GABAergic cell groups and, further, confers vesicular GABA transport with the expected properties on heterologous expression. The sequence predicts 10 TMDs and a relatively large cytoplasmic amino terminus.In addition, it defines a novel family of vesicular neurotransmitter transports that may also include a transporter for the principal excitatory neurotransmitter, glutamate.
40. Kish PE, Fischer-Bovenkerk C, Ueda T. Active transport of gamma-aminobutyric acid and glycine into synaptic vesicles. Proc Natl Acad Sci USA. 86:1989;3877-3881.
41. Burger PM, Hell J, Mehl E, Krasel C, Lottspeich F, Jahn R. GABA and glycine in synaptic vesicles: storage and transport characteristics. Neuron. 7:1991;287-293.
42. Sagne C, El Mestikawy S, Isambert M-F, Hamon M, Henry J-P, Giros B, Gasnier B. Cloning of a functional vesicular GABA and glycine transporter by screening of genome databases. FEBS Lett. 417:1997;177-183.
43. Ozkan ED, Lee FS, Ueda T. A protein factor that inhibits ATP-dependent glutamate and γ-aminobutyric acid accumulation into synaptic vesicles: purification and initial characterization. of special interest Proc Natl Acad Sci USA. 94:1997;4137-4142 Using native synaptic vesicles to assay vesicular glutamate and GABA transport, an inhibitory protein was identified as a proteolytic fragment of fodrin, suggesting a novel interaction between synaptic vesicles and the cytoskeleton.
44. Fischer WN, Kwart M, Hummel S, Frommer WB. Substrate specificity and expression profile of amino acid transporters (AAPs) in Arabidopsis. J Biol Chem. 270:1995;16315-16320.